Skip to main content
Equibles
SBRA logo

SBRA

Sabra Health Care REIT, Inc.
$19.62 -0.26 (-1.31%) At close · Jul 10
Market Cap
$4.95B
Shares
252,190,095

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$19.62 Open$19.88 Day$19.44–19.94 52W$16.64–21.28 Avg vol 30d3.5M Short int26.4M · 10.5% float · 6.1d Short vol55% Last earningsApr 29, 2026 DataJan 2020–Jul 2026 Filing10-Q · Apr 29
Up next
Next earnings call
Jul 30, 2026 Est · unconfirmed · in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Apr 29, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Low
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +1%
      above
      Price vs 50-day avg −0%
      below
      RSI (14) 52
      neutral
      MACD trend Positive
      52-week position 64%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Strong
      1-month return +4%
      trailing
      6-month return +5%
      trailing
      YTD return +5%
      this year
      Relative strength −5%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $20 › 200d $19 — 50d above 200d
      Institutional flow Accumulating
      17 of 459 funds reported for Jun 30 · net +66.6K sh shares · +1 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      10.46% of float · ▼ -0.6% MoM · 6.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      459 holders — near 3-yr high, broad support
      Squeeze score 67
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +10%
      Y/Y
      EPS growth +19%
      Y/Y
      Valuation P/E 31.1
      below peers
      Balance sheet $2.5B
      net debt
      Quant / Vol
      risk profile
      Low
      Volatility 22%
      annualized · 1-yr
      Max drawdown −17%
      past year
      ATR 2.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record
      Beat or met 0 of last 2
      Latest guidance · from the 8-K filed Feb 12, 2026
      Net Income · 2026 Initiated $0.60 – $0.64
      prior FY $0.64 midpoint −3.1% Y/Y
      FFO · 2026 Initiated $1.49 – $1.53
      Normalized FFO · 2026 Initiated $1.49 – $1.53
      AFFO · 2026 Initiated $1.55 – $1.59
      Normalized AFFO · 2026 Initiated $1.55 – $1.59
      Guided vs delivered · last 2 settled
      Net Income 2025
      $0.06 Miss −90.9%
      Net income full-year 2024
      $-0.34 Miss −170.1%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 5 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +1% Bullish
      Price vs 50-day avg
      −0% Neutral
      RSI (14)
      52 Neutral
      MACD trend
      Positive Bullish
      52-week position
      64% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $20 › 200d $19 — 50d above 200d
      Institutional flow Accumulating
      17 of 459 funds reported for Jun 30 · net +66.6K sh shares · +1 new
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      10.46% of float · ▼ -0.6% MoM · 6.1 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      459 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $17 Now $20 · 64% 52-wk high $21
      vs 200-day avg +1% vs 50-day avg 0%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Available under current ATM program $353.4M Q1 2026 —
      Initial weighted average price of shares sold under forward ATM $20.19 Q1 2026 —
      Investments closed year to date $206.1M Q1 2026 —
      Liquidity $1.2B Q1 2026 —
      Net Debt to Adjusted EBITDA non-GAAP 5.04 Q1 2026 —
      Other loans 10 Q1 2026 —
      Same property managed senior housing Cash NOI year-over-year change 14.4% Q1 2026 —
      Shares remaining outstanding under forward sale agreements 23.7M Q1 2026 —
      Unrestricted cash and cash equivalents $116.5M Q1 2026 —
      Weighted average price of shares under forward sale agreements $19.03 Q1 2026 —
      cost of permanent debt 3.92% Q1 FY2026 call —
      managed senior housing Cash NOI non-GAAP $39M Q1 FY2026 call —
      managed senior housing portfolio margin expansion 60 Q1 FY2026 call —
      managed senior housing portfolio sequential cash NOI growth 9.5% Q1 FY2026 call —
      managed senior housing portfolio sequential revenue growth 7.2% Q1 FY2026 call —
      net debt to adjusted EBITDA ratio non-GAAP 5.04 Q1 FY2026 call —
      normalized AFFO non-GAAP $100.6M Q1 FY2026 call —
      normalized AFFO per share non-GAAP $0.39 Q1 FY2026 call —
      normalized FFO non-GAAP $96.1M Q1 FY2026 call —
      normalized FFO per share non-GAAP $0.38 Q1 FY2026 call —
      private pay concentration 50% Q1 FY2026 call —
      same-store managed senior housing Canadian communities revenue growth 9.6% Q1 FY2026 call —
      same-store managed senior housing Canadian portfolio occupancy 93.4% Q1 FY2026 call —
      same-store managed senior housing Canadian portfolio RevPAR growth 6.5% Q1 FY2026 call —
      same-store managed senior housing cash NOI growth 14.4% Q1 FY2026 call —
      same-store managed senior housing domestic portfolio occupancy 85.6% Q1 FY2026 call —
      same-store managed senior housing expense per occupied room growth 1.8% Q1 FY2026 call —
      same-store managed senior housing occupancy 88.4% Q1 FY2026 call —
      same-store managed senior housing revenue growth 7.9% Q1 FY2026 call —
      same-store managed senior housing RevPAR growth 4.6% Q1 FY2026 call —
      EBITDARM Coverage - Behavioral Health, Specialty Hospitals and Other non-GAAP 3.99 Q4 2025 —
      Same property managed senior housing Cash NOI growth non-GAAP 12.6% Q4 2025 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      SBRA
      Sabra Health Care REIT, Inc.
      this stock
      		$4.95B +5.1% +3.6% 31.1 10.5%
      WELL
      Welltower Inc.
      		 $163.48B +25.2% +35.6% 115.2 2.7%
      VTR
      Ventas, Inc.
      		 $44.08B +17.9% +18.5% 164.8 4.7%
      DOC
      Healthpeak Properties, Inc.
      		 $14.93B +37.1% +4.5% 67.7 3.9%
      OHI
      Omega Healthcare Investors Inc
      		 $14.38B +10.6% +13.2% 23.2 4.7%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      460
      % held
      93.4%
      Reported
      17 of 459
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      418
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      26.4M
      Days to cover
      6.1d
      Change
      -166.5K sh
      View
      Short Volume
      Short vol %
      55%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      17.5K
      Value
      $324.2K
      As of
      Jun 12, 2026
      View
      Off-Exchange
      Off-exchange %
      42.8%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Apr 10, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $774.6M
      Net income (FY)
      $155.6M
      EPS diluted
      $0.64
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 17, 2026
      This year
      8
      View
      Proposed Sales
      Value
      $192.5K
      Shares
      11.0K
      Filed
      May 15, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 17, 2026
      View
      Investor Relations
      Latest news
      Sabra Health Care REIT, Inc., Iss…
      Published
      May 28, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      SBRA -2.7% +4.3% +4.5% +0.6% +5.2%
      SPY +1.4% +4.1% +9.1% +1.1% +10.7%
      vs SPY -4.1% +0.2% -4.5% -0.5% -5.6%

      Capital returns

      Latest dividend
      $0.30 / share · ex May 15, 2026
      Paid (TTM)
      $1.20 / share · 4 payouts
      Dividend yield (TTM, derived)
      6.12%

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1492298 CUSIP 78573L106 13F (30d) 49 filings 20 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)